Market Overview

Soft Tissue Sarcoma - Pipeline Insight, 2018 Report - ResearchAndMarkets.com

Share:

The "Soft
Tissue Sarcoma - Pipeline Insight, 2018"
drug pipelines has
been added to ResearchAndMarkets.com's offering.

'Soft Tissue Sarcoma - Pipeline Insight, 2018' report offers
comprehensive Insight of the pipeline (under development) therapeutics
scenario and growth prospects across Soft Tissue Sarcoma development.

The report provides detailed coverage of the pipeline landscape for this
mechanism of action, equipped with data from multiple sources with
complete pipeline analysis by developmental stage, associated
indications, route of administration and molecule type.

Pipeline therapeutics development coverage provides descriptive product
profiles including (but not limited to) drug description, product
development and R&D activities encompassing clinical and pre-clinical
studies, designations, collaborations, licensing deals, grants,
technologies and patent details.

Key Topics Covered:

1. Report Introduction

2. Soft Tissue Sarcoma Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Soft Tissue Sarcoma

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Mentioned

  • Philogen
  • Novartis
  • Adaptimmune
  • NewVac
  • Pharma Mar
  • CASI Pharmaceutical

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/qk459t/soft_tissue?w=4

View Comments and Join the Discussion!